TearClear is a specialty ophthalmic pharmaceutical company developing branded, multi-dose solutions. We believe our proprietary system may have the potential to help reduce adverse events from preservatives.
What People are Saying
BAK has been shown to be a significant cause of a host of adverse events with prolonged use… TearClear’s technology offers a compelling and differentiated approach to eliminating the preservative before delivery while allowing it to preserve sterility within the bottle.Richard Lindstrom, MD
Ophthalmology has been looking to address this unmet need for a long time. TearClear is developing a simple and effective technology that will truly benefit the patient.Bill Link, PhD